Emergency Contraception - Greece

Date: March 22, 2010
Pages: 33
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: EA891BECC8CEN
Leaflet:

Download PDF Leaflet

Emergency contraception is still prescription-bound in Greece, with this continuing to be the main reason for a generally moderate size of less than EUR1 million estimated under-the-counter sales and quite unpredictable growth rates. Despite the legal framework behind its status, emergency contraception is available under-the-counter in Greece. The prescription-bound status of the products however makes advertising impossible and therefore any promotions made are directly linked with doctors...

Euromonitor International's Emergency Contraception Products in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage:

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Emergency Contraception in Greece
Euromonitor International
March 2010

LIST OF CONTENTS AND TABLES

Executive Summary
Recession Has Marginal Effect on Consumer Healthcare
Smokers and Obese Consumers Drive Sales
Scepticism and Loyalty Continues To Hinder New Entrants
Healthfood Stores Continue To Expand
Recession Expected To Bypass Consumer Healthcare
Key Trends and Developments
Merging Health and Beauty Trends Impact Healthcare
Effects of the Recession and Growing Price Awareness
Contemporary Lifestyles Offer Prosperous Ground for Growth
Reluctance and Scepticism About Product Effectiveness Still Hinders Penetration
Manufacturers Acknowledge the Significance of Communication
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Penetration of Private Label by Sector 2004-2009
  Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Advertising
Packaging
Labelling
Distribution
Pricing
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Definitions
  Summary 1 Research Sources
Alapis Pharma SA
Strategic Direction
Key Facts
  Summary 2 Alapis Pharma SA: Key Facts
  Summary 3 Alapis Pharma SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 4 Alapis Pharma SA: Competitive Position 2009
Elpen SA
Strategic Direction
Key Facts
  Summary 5 Elpen SA: Key Facts
  Summary 6 Elpen SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 7 Elpen SA: Competitive Position 2009
Iso Plus SA
Strategic Direction
Key Facts
  Summary 8 Iso Plus SA: Key Facts
  Summary 9 Iso Plus SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 10 Iso Plus SA: Competitive Position 2009
Korres Natural Products SA
Strategic Direction
Key Facts
  Summary 11 Korres Natural Products SA: Key Facts
  Summary 12 Korres Natural Products SA: Operational Indicators
Company Background
Production
Competitive Positioning
Power Health Hellas SA
Strategic Direction
Key Facts
  Summary 14 Power Health Hellas SA: Key Facts
  Summary 15 Power Health Hellas SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 16 Power Health Hellas SA: Competitive Position 2009
Trends
Category Data
  Table 12 Sales of Emergency Contraception: Value 2005-2009
  Table 13 Sales of Emergency Contraception: % Value Growth 2005-2009
  Table 14 Emergency Contraception Company Shares by Value 2005-2009
  Table 15 Emergency Contraception Brand Shares by Value 2006-2009
  Table 16 Forecast Sales of Emergency Contraception: Value 2009-2014
  Table 17 Forecast Sales of Emergency Contraception: % Value Growth 2009-2014
Skip to top


Emergency Contraception in India US$ 990.00 Jul, 2013 · 31 pages
Emergency Contraception - Iran US$ 990.00 May, 2010 · 22 pages

Ask Your Question

Emergency Contraception - Greece
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: